CN104784293A - Traditional Chinese medicine composition for treating extensive heat type subacute eczema - Google Patents
Traditional Chinese medicine composition for treating extensive heat type subacute eczema Download PDFInfo
- Publication number
- CN104784293A CN104784293A CN201510163420.6A CN201510163420A CN104784293A CN 104784293 A CN104784293 A CN 104784293A CN 201510163420 A CN201510163420 A CN 201510163420A CN 104784293 A CN104784293 A CN 104784293A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- herba
- medicine composition
- radix
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses traditional Chinese medicine composition for treating extensive heat type subacute eczema. The traditional Chinese medicine composition is prepared from hypericum japonicum, Chinese osbeckia herb, buttonbush roots, roots of pilular adina, all grass of ainsliaea fragrans champ, straightstalk alpine meadowrue roots, multibract raspberry roots, persicaria chinensis, senecio dianthus franch and kalanchoe laciniata. A clinical test shows that the traditional Chinese medicine composition has functions of exudation resistance and reduction of celluar edema by reducing capillary permeability and plays a role in inhibiting cell proliferation and irritability inflammatory reaction in different degrees, the total effective rate reaches 96%, and the curative effect is remarkable.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition, particularly relate to a kind of Chinese medicine composition for the treatment of excessive heat type subacute eczema.
Background technology
The cause of disease of eczema is complicated, and develop into the transition of chronic eczema as acute eczema, the therapeutic effect of subacute eczema directly affects the course of disease of eczema and lapses to.Subacute eczema Chinese medical discrimination is based on excessive heat type clinically.Excessive heat type subacute eczema system acute eczema transfers chronic important stage to, and the cause of disease is that damp accumulates heat-transformation of a specified duration, and damp-heat gluing each other is sent out in skin.Though Western medicine curative effect is certainly, its toxic and side effects of long-term taking is large, and the dependence easily formed such medicine and drug resistance.Chinese medicine is from entirety, focus in overall pathological change that local patholoic change causes, and local pathological change and overall pathological reaction are united, treating both the principal and secondary aspects of a disease can be accomplished, there is good curative effect improving in clinical symptoms and prevention of recurrence, and Chinese medicine preparation to meet in the traditional Chinese medical science appropriate technology letter, just, test, honest and clean feature, easily accepted by patient, painful little, medicine valency is cheap, has no side effect, and does not limit by environment, its therapeutic effect is better than simple western medical treatment, is worth using at clinical expansion.
Summary of the invention
The object of this invention is to provide a kind of Chinese medicine composition for the treatment of excessive heat type subacute eczema.This Chinese medicine composition having exudation, reducing cellular edema effect by reducing capillary permeability; And serve the effect of antiproliferative effect and allergic inflammation reaction to some extent.
The object of the invention is to be achieved through the following technical solutions, the Chinese medicine composition of this treatment excessive heat type subacute eczema is made up of the Chinese medicine of following weight portion: Herba Hyperici Japonici 15-30 part, Herba Osbeckiae 9-15 part, Radix Cephalanthi Occidentalis 30-40 part, Radix Adinae Piluliferae 15-25 part, Herba Ainsliaeae Fragrantis 9-15 part, Radix Thalictri elati 3-9 part, Radix Rubi multibracteai 15-25 part, Herb Polygoni Chinensis 15-30 part, Herba Senecionis Dianthui 3-9 part, Herba Kalanchoes Laciniatae 9-15 part.
Preferably, Herba Hyperici Japonici 25 parts, Herba Osbeckiae 12 parts, Radix Cephalanthi Occidentalis 35 parts, the Radix Adinae Piluliferae 20 parts, Herba Ainsliaeae Fragrantis 12 parts, Radix Thalictri elati 6 parts, Radix Rubi multibracteai 20 parts, Herb Polygoni Chinensis 23 parts, Herba Senecionis Dianthui 6 parts, Herba Kalanchoes Laciniatae 12 parts.
Above-mentioned Chinese medicine decocting is made decoction by preparation method.
Fang Zhong: Herba Hyperici Japonici heat clearing and damp drying, removing toxic substances, detumescence; Herba Osbeckiae clearing away heat-damp and promoting diuresis, removing toxic substances, detumescence, hemostasis; Radix Cephalanthi Occidentalis clearing away heat and eliminating dampness, removing blood stasis to reduce swelling; Radix Adinae Piluliferae clearing away heat-damp and promoting diuresis, clots absorbing are subsided a swelling; Herba Ainsliaeae Fragrantis removing heat from blood, removing toxic substances, clearing away heat-damp and promoting diuresis; Radix Thalictri elati removing heat from blood, removing toxic substances, clearing away heat-damp and promoting diuresis; Radix Rubi multibracteai clearing away heat-damp and promoting diuresis, removing heat from blood, removing toxic substances, pain relieving; Herb Polygoni Chinensis heat-clearing and toxic substances removing, dampness removing, removing heat from blood; Herba Senecionis Dianthui heat-clearing and toxic substances removing, dispeiling pathogenic wind and removing dampness, antipruritic; Herba Kalanchoes Laciniatae detumescence dissipating blood stasis, heat-clearing and toxic substances removing, hemostasis.
Clinical data
1. physical data 120 example is my institute Dermatology Outpatient Department patient, and 120 routine patients adopt lottery to be divided into two groups at random.Treatment group 70 example, man 43 example, female 27 example; 15 ~ 65 years old age, average 44.2 years old; Site of pathological change: women's head-ornaments 14 example, perineum 10 example, extremity 20 example, whole body 26 example.Matched group 50 example, man 30 example, female 20 example; 15 ~ 64 years old age, average 43.7 years old; Site of pathological change: women's head-ornaments 10 example, perineum 8 example, extremity 19 example, whole body 13 example.Equal 3 ~ 6 weeks of two groups of courses of disease.The equal P > 0.05 of clinical data such as two groups of ages, sex, sick position and courses of disease, there are no significant for difference, has comparability.
2. diagnostic criteria is promulgated with reference to State Administration of Traditional Chinese Medicine " Chinese medical disease Standardization of diagnosis and curative effect " is diagnosed as subacute eczema.Chinese medical discrimination is excessive heat type.All do not use hormones Drug therapy, and eliminating suffers from Other diseases.
3. Therapeutic Method treatment group medicine composition: Herba Hyperici Japonici 25g, Herba Osbeckiae 12g, Radix Cephalanthi Occidentalis 35g, Radix Adinae Piluliferae 20g, Herba Ainsliaeae Fragrantis 12g, Radix Thalictri elati 6g, Radix Rubi multibracteai 20g, Herb Polygoni Chinensis 23g, Herba Senecionis Dianthui 6g, Herba Kalanchoes Laciniatae 12g.Be decocted in water for oral dose, 1 day 1 dose, within 1 week, be 1 course for the treatment of, take 3 courses for the treatment of altogether.Matched group gives Pifubing Xuedu Pill, and (Beijing TongrenTang Pharmaceutical Co., Ltd produces, lot number: 9903268), each 20, and every day respectively takes 1 time sooner or later, within 1 week, is 1 course for the treatment of, takes 3 courses for the treatment of altogether.Nursing aspect it should be noted that close observation skin lesion situation, and has no adverse reaction after patient on medication, and treatments period skin lesion has when oozing out, and all uses the outer soak of 3% borate.
4. criterion of therapeutical effect is with reference to " the Chinese medical disease Standardization of diagnosis and curative effect " of the enforcement of State Administration of Traditional Chinese Medicine's nineteen ninety-five, clinical recovery: pruritus disappears, and skin lesion disappears substantially; Effective: pruritus significantly alleviates, skin lesion obviously improves; Effective: pruritus alleviates, skin lesion makes moderate progress; Invalid: pruritus and skin lesion are without improvement.Clinical recovery rate+obvious effective rate is total effective rate.
5. observe the curative effect after therapeutic outcome patient treatment, treatment group: 30 examples of fully recovering (43%), effective 20 examples (29%), effective 17 examples (24%), invalid 3 examples (4%), total effective rate 96%.Matched group: 25 examples of fully recovering (50%), effective 10 examples (20%), effective 3 examples (6%), invalid 12 examples (24%), total effective rate 76%.Treatment group total effective rate is significantly higher than matched group.All promoting the circulation of blood before and after two groups of treatments, routine urinalysis and hepatic and renal function measure and are showed no exception.
Medical record is illustrated
Example: Lee, female, 25 years old, first visit on October 9 in 2013.Women's head-ornaments and extremity symmetry erythema, pimple, the papulovesicle bimester of near, a small amount of rotten to the corn and crust, pruritus unbearably, recurrent exerbation.Disease aggravation before nearly one week, large dry stool, red tongue, yellow and greasy fur, stringy and rolling pulse, Western medicine diagnose: subacute eczema; Tcm diagnosis: noxious dampness infections.Chinese medical discrimination belongs to damp and hot contamination.Side uses this Chinese medicine composition, decocting decoction being taken warmly, day 1 dose; The soak of external 3% borate.The pungent irritable food of treatments period fasting, emotion regulation.Further consultation on October 16 in 2013, the minimizing of skin lesion district reaches 50%, and the diseases such as pruritus all alleviate.Take again 7 doses, front and heal.
Detailed description of the invention
Embodiment one: take Herba Hyperici Japonici 25g, Herba Osbeckiae 12g, Radix Cephalanthi Occidentalis 35g, Radix Adinae Piluliferae 20g, Herba Ainsliaeae Fragrantis 12g, Radix Thalictri elati 6g, Radix Rubi multibracteai 20g, Herb Polygoni Chinensis 23g, Herba Senecionis Dianthui 6g, Herba Kalanchoes Laciniatae 12g, makes decoction by above-mentioned Chinese medicine decocting.
Embodiment two: take Herba Hyperici Japonici 30g, Herba Osbeckiae 15g, Radix Cephalanthi Occidentalis 40g, Radix Adinae Piluliferae 25g, Herba Ainsliaeae Fragrantis 15g, Radix Thalictri elati 9g, Radix Rubi multibracteai 25g, Herb Polygoni Chinensis 30g, Herba Senecionis Dianthui 9g, Herba Kalanchoes Laciniatae 15g, makes decoction by above-mentioned Chinese medicine decocting.
Embodiment three: take Herba Hyperici Japonici 15g, Herba Osbeckiae 9g, Radix Cephalanthi Occidentalis 30g, Radix Adinae Piluliferae 15g, Herba Ainsliaeae Fragrantis 9g, Radix Thalictri elati 3g, Radix Rubi multibracteai 15g, Herb Polygoni Chinensis 15g, Herba Senecionis Dianthui 3g, Herba Kalanchoes Laciniatae 9g, makes decoction by above-mentioned Chinese medicine decocting.
Claims (2)
1. treat a Chinese medicine composition for excessive heat type subacute eczema, it is characterized in that this Chinese medicine composition is made up of the Chinese medicine of following weight portion: Herba Hyperici Japonici 15-30 part, Herba Osbeckiae 9-15 part, Radix Cephalanthi Occidentalis 30-40 part, Radix Adinae Piluliferae 15-25 part, Herba Ainsliaeae Fragrantis 9-15 part, Radix Thalictri elati 3-9 part, Radix Rubi multibracteai 15-25 part, Herb Polygoni Chinensis 15-30 part, Herba Senecionis Dianthui 3-9 part, Herba Kalanchoes Laciniatae 9-15 part.
2. a kind of Chinese medicine composition for the treatment of excessive heat type subacute eczema as claimed in claim 1, is characterized in that this Chinese medicine composition is made up of the Chinese medicine of following weight portion: Herba Hyperici Japonici 25 parts, Herba Osbeckiae 12 parts, Radix Cephalanthi Occidentalis 35 parts, the Radix Adinae Piluliferae 20 parts, Herba Ainsliaeae Fragrantis 12 parts, Radix Thalictri elati 6 parts, Radix Rubi multibracteai 20 parts, Herb Polygoni Chinensis 23 parts, Herba Senecionis Dianthui 6 parts, Herba Kalanchoes Laciniatae 12 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510163420.6A CN104784293A (en) | 2015-03-30 | 2015-03-30 | Traditional Chinese medicine composition for treating extensive heat type subacute eczema |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510163420.6A CN104784293A (en) | 2015-03-30 | 2015-03-30 | Traditional Chinese medicine composition for treating extensive heat type subacute eczema |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104784293A true CN104784293A (en) | 2015-07-22 |
Family
ID=53549791
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510163420.6A Pending CN104784293A (en) | 2015-03-30 | 2015-03-30 | Traditional Chinese medicine composition for treating extensive heat type subacute eczema |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104784293A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109364069A (en) * | 2018-11-07 | 2019-02-22 | 魏姗姗 | Zygadenine is preparing the purposes in therapeutic agents for allergic diseases |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101199652A (en) * | 2006-12-15 | 2008-06-18 | 李义海 | Medicament for treating acute, subacute eczema and preparing method thereof |
-
2015
- 2015-03-30 CN CN201510163420.6A patent/CN104784293A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101199652A (en) * | 2006-12-15 | 2008-06-18 | 李义海 | Medicament for treating acute, subacute eczema and preparing method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 陈茂仁等: "中西医结合治疗湿疹3例", 《蛇志》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109364069A (en) * | 2018-11-07 | 2019-02-22 | 魏姗姗 | Zygadenine is preparing the purposes in therapeutic agents for allergic diseases |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103341145B (en) | Traditional Chinese medicine for treating psoriasis and preparation method thereof | |
| CN103720902A (en) | Traditional Chinese medicine used for anorectal surgery wound healing and preparation method thereof | |
| CN103463267A (en) | Healthcare traditional Chinese medicine liquid for external application and preparation process thereof | |
| CN102727758A (en) | Traditional Chinese medicine enema for treating ulcerative colitis | |
| CN103169883B (en) | Traditional Chinese medicine for treating infantile jaundice | |
| CN103908600B (en) | The external used medicine for the treatment of rheumatoid arthritis damp-heat arthralgia resistance card and preparation method | |
| CN101537149A (en) | Pharmaceutical composition for curing eczema | |
| CN106039109A (en) | Traditional Chinese medicinal liquor for preventing and treating cold dampness accumulation pattern rheumatoid arthritis | |
| CN104784293A (en) | Traditional Chinese medicine composition for treating extensive heat type subacute eczema | |
| CN102824578B (en) | Traditional Chinese medicine for treating gout | |
| CN105362349A (en) | Traditional Chinese medicine external-use lotion for treating palmoplantar eczema and nursing method | |
| CN103463340B (en) | One treats migrainous Chinese medicine preparation | |
| CN103705778B (en) | A kind of cataplasm of tcm treating contact dermatitis of face | |
| CN102920799B (en) | A kind of liniment treating gout and preparation method thereof | |
| CN103623122B (en) | A kind of Chinese medicine for hemorrhoid and preparation method thereof | |
| CN102188643B (en) | Medicament for treating damp-heat blockage syndrome and its preparation method | |
| CN101391053B (en) | Traditional Chinese medicine composition for treating hemorrhoid | |
| CN101829188B (en) | Medicament for treating urinary infection and lithiasis | |
| CN101732425B (en) | Externally-applied medicine composite for psoriasis | |
| CN105641326A (en) | Treatment method for treating ulcerative colitis by combining codonopsis pilosula-radix astragali intestine-tonifying soup with ulcerative colitis enema liquid | |
| CN103705779B (en) | A kind of Chinese medicine composition treating contact dermatitis of face | |
| CN104257835B (en) | A kind of external washout with traditional Chinese herbs agent treating gestation skin pruritus | |
| CN103494924B (en) | Chinese medicine composition for treating damp-heat stagnation acne | |
| CN105168868A (en) | Traditional Chinese medicine for treating thyroiditis and preparing method thereof | |
| CN102283980B (en) | Medicament for treating damp and heat swelling type chronic kidney disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| EXSB | Decision made by sipo to initiate substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150722 |
|
| WD01 | Invention patent application deemed withdrawn after publication |